Carregant...
The Goldilocks Window of Personalized Chemotherapy: Getting the Immune Response Just Right
The immune system is a robust and often untapped accomplice of many standard cancer therapies. A majority of tumors exist in a state of immune tolerance where the patient’s immune system has become insensitive to the cancer cells. Due to its lymphodepleting effects, chemotherapy has the potential to...
Guardat en:
| Publicat a: | Cancer Res |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6801094/ https://ncbi.nlm.nih.gov/pubmed/31387920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-18-3712 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|